US Stock MarketDetailed Quotes

Citius Pharmaceuticals (CTXR)

Watchlist
  • 0.8495
  • +0.0495+6.19%
Close Jan 22 16:00 ET
  • 0.8409
  • -0.0086-1.01%
Post 19:58 ET
17.64MMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals (CTXR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.26%38.53M
-23.65%8.44M
-17.36%8.79M
2.65%11.26M
7.48%10.04M
14.33%42M
9.14%11.05M
22.63%10.63M
2.67%10.97M
28.84%9.34M
Selling and administrative expenses
-2.39%29.37M
-16.47%6.8M
-8.94%7.17M
1.76%7.49M
17.77%7.91M
37.32%30.09M
12.34%8.14M
60.38%7.87M
23.59%7.36M
76.61%6.72M
-General and administrative expense
-2.39%29.37M
-16.47%6.8M
-8.94%7.17M
1.76%7.49M
17.77%7.91M
37.32%30.09M
12.34%8.14M
60.38%7.87M
23.59%7.36M
76.61%6.72M
Research and development costs
-23.10%9.16M
-43.68%1.64M
-41.34%1.62M
4.45%3.77M
-18.87%2.13M
-19.66%11.91M
1.12%2.91M
-26.58%2.76M
-23.71%3.61M
-23.90%2.62M
Operating profit
8.26%-38.53M
23.65%-8.44M
17.36%-8.79M
-2.65%-11.26M
-7.48%-10.04M
-14.33%-42M
-9.14%-11.05M
-22.63%-10.63M
-2.67%-10.97M
-28.84%-9.34M
Net non-operating interest income expense
-120.80%-157.7K
-135.88%-42.1K
-174.02%-151.63K
-92.64%13.41K
-91.09%22.61K
-35.73%758K
-63.88%117.31K
-39.18%204.84K
-39.92%182.21K
18.22%253.64K
Non-operating interest income
-85.48%110.08K
-54.46%53.42K
-89.93%20.64K
-92.64%13.41K
-91.09%22.61K
-35.73%758K
-63.88%117.31K
-39.18%204.84K
-39.92%182.21K
18.22%253.64K
Non-operating interest expense
--267.78K
--95.52K
--172.26K
----
----
----
----
--0
----
----
Other net income (expense)
-33.41%2.39M
0
2.39M
Other non- operating income (expenses)
----
----
----
----
----
-33.41%2.39M
--0
----
--2.39M
----
Income before tax
0.43%-38.68M
22.44%-8.48M
14.28%-8.94M
-33.89%-11.25M
-10.23%-10.02M
-21.53%-38.85M
-11.56%-10.93M
-25.12%-10.43M
19.09%-8.4M
-163.42%-9.09M
Income tax
83.50%1.06M
83.50%264.24K
83.50%264.24K
83.50%264.24K
83.50%264.24K
0.00%576K
0.00%144K
0.00%144K
0.00%144K
0.00%144K
Net income
-0.80%-39.74M
21.07%-8.74M
12.95%-9.2M
-34.73%-11.51M
-11.38%-10.28M
-21.15%-39.43M
-11.40%-11.08M
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
Net income continuous Operations
-0.80%-39.74M
21.07%-8.74M
12.95%-9.2M
-34.73%-11.51M
-11.38%-10.28M
-21.15%-39.43M
-11.40%-11.08M
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
Minority interest income
-703.61%-2.31M
-173.30%-784.36K
-414K
-595K
-513K
-287K
-287K
0
0
0
Net income attributable to the parent company
4.36%-37.43M
26.24%-7.96M
16.87%-8.79M
-27.77%-10.92M
-5.82%-9.77M
-20.27%-39.14M
-8.51%-10.79M
-24.70%-10.57M
18.83%-8.54M
-156.88%-9.23M
Preferred stock dividends
Other preferred stock dividends
0
0
0
-9.02%1.05M
-36.96%725.75K
321.56K
Net income attributable to common stockholders
6.85%-37.43M
30.88%-7.96M
19.32%-8.79M
-27.77%-10.92M
-5.82%-9.77M
-19.27%-40.19M
-3.79%-11.52M
-28.49%-10.89M
18.83%-8.54M
-156.88%-9.23M
Basic earnings per share
43.38%-3.38
72.47%-0.4405
49.04%-0.8
5.22%-1.27
10.34%-1.3
-7.18%-5.97
12.09%-1.6
-4.67%-1.57
23.43%-1.34
-190.00%-1.45
Diluted earnings per share
43.38%-3.38
72.47%-0.4405
49.04%-0.8
5.22%-1.27
10.34%-1.3
-7.18%-5.97
12.09%-1.6
-4.67%-1.57
23.43%-1.34
-190.00%-1.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.26%38.53M-23.65%8.44M-17.36%8.79M2.65%11.26M7.48%10.04M14.33%42M9.14%11.05M22.63%10.63M2.67%10.97M28.84%9.34M
Selling and administrative expenses -2.39%29.37M-16.47%6.8M-8.94%7.17M1.76%7.49M17.77%7.91M37.32%30.09M12.34%8.14M60.38%7.87M23.59%7.36M76.61%6.72M
-General and administrative expense -2.39%29.37M-16.47%6.8M-8.94%7.17M1.76%7.49M17.77%7.91M37.32%30.09M12.34%8.14M60.38%7.87M23.59%7.36M76.61%6.72M
Research and development costs -23.10%9.16M-43.68%1.64M-41.34%1.62M4.45%3.77M-18.87%2.13M-19.66%11.91M1.12%2.91M-26.58%2.76M-23.71%3.61M-23.90%2.62M
Operating profit 8.26%-38.53M23.65%-8.44M17.36%-8.79M-2.65%-11.26M-7.48%-10.04M-14.33%-42M-9.14%-11.05M-22.63%-10.63M-2.67%-10.97M-28.84%-9.34M
Net non-operating interest income expense -120.80%-157.7K-135.88%-42.1K-174.02%-151.63K-92.64%13.41K-91.09%22.61K-35.73%758K-63.88%117.31K-39.18%204.84K-39.92%182.21K18.22%253.64K
Non-operating interest income -85.48%110.08K-54.46%53.42K-89.93%20.64K-92.64%13.41K-91.09%22.61K-35.73%758K-63.88%117.31K-39.18%204.84K-39.92%182.21K18.22%253.64K
Non-operating interest expense --267.78K--95.52K--172.26K------------------0--------
Other net income (expense) -33.41%2.39M02.39M
Other non- operating income (expenses) ---------------------33.41%2.39M--0------2.39M----
Income before tax 0.43%-38.68M22.44%-8.48M14.28%-8.94M-33.89%-11.25M-10.23%-10.02M-21.53%-38.85M-11.56%-10.93M-25.12%-10.43M19.09%-8.4M-163.42%-9.09M
Income tax 83.50%1.06M83.50%264.24K83.50%264.24K83.50%264.24K83.50%264.24K0.00%576K0.00%144K0.00%144K0.00%144K0.00%144K
Net income -0.80%-39.74M21.07%-8.74M12.95%-9.2M-34.73%-11.51M-11.38%-10.28M-21.15%-39.43M-11.40%-11.08M-24.70%-10.57M18.83%-8.54M-156.88%-9.23M
Net income continuous Operations -0.80%-39.74M21.07%-8.74M12.95%-9.2M-34.73%-11.51M-11.38%-10.28M-21.15%-39.43M-11.40%-11.08M-24.70%-10.57M18.83%-8.54M-156.88%-9.23M
Minority interest income -703.61%-2.31M-173.30%-784.36K-414K-595K-513K-287K-287K000
Net income attributable to the parent company 4.36%-37.43M26.24%-7.96M16.87%-8.79M-27.77%-10.92M-5.82%-9.77M-20.27%-39.14M-8.51%-10.79M-24.70%-10.57M18.83%-8.54M-156.88%-9.23M
Preferred stock dividends
Other preferred stock dividends 000-9.02%1.05M-36.96%725.75K321.56K
Net income attributable to common stockholders 6.85%-37.43M30.88%-7.96M19.32%-8.79M-27.77%-10.92M-5.82%-9.77M-19.27%-40.19M-3.79%-11.52M-28.49%-10.89M18.83%-8.54M-156.88%-9.23M
Basic earnings per share 43.38%-3.3872.47%-0.440549.04%-0.85.22%-1.2710.34%-1.3-7.18%-5.9712.09%-1.6-4.67%-1.5723.43%-1.34-190.00%-1.45
Diluted earnings per share 43.38%-3.3872.47%-0.440549.04%-0.85.22%-1.2710.34%-1.3-7.18%-5.9712.09%-1.6-4.67%-1.5723.43%-1.34-190.00%-1.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -